DCGO

DOCGO INC

• Reuters·1d ago

  Halper Sadeh probes DocGo directors for alleged fiduciary duty breaches

• Reuters·03/02 12:35

  DocGo Inc. published an update to their financial calendar

• Dow Jones·03/02 12:35

  Press Release: DocGo to Announce Fourth Quarter and Full Year 2025 Results on Monday, March 16, 2026

• Reuters·02/17 12:35

  DocGo CEO to Present at TD Cowen Health Care Conference

• TipRanks·01/30 22:28

  DocGo Receives Nasdaq Notice Over Minimum Bid Price

• Reuters·01/30 22:13

  DocGo Inc. Faces Nasdaq Delisting Risk Over Minimum Bid Price Compliance

• Reuters·01/27 12:35

  DOCGO INC: STEADYMD ANNOUNCES IMMEDIATE EXPANSION OF CLINICAL WORKFORCE TO MEET RISING DEMAND FOR BRANDED GLP-1 WEIGHT LOSS CARE

• TipRanks·01/15 11:10

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NTLA) and DocGo (DCGO)

• TipRanks·01/05 13:16

  Stifel Nicolaus Reaffirms Their Buy Rating on DocGo (DCGO)

• Reuters·01/05 12:35

  DocGo CFO to Hold Fireside Chat at Needham Growth Conference

• TipRanks·12/12/2025 21:32

  DocGo Extends Share Repurchase Program to 2026

• Reuters·11/26/2025 12:35

  DocGo Inc. CEO to Present at Key Investor Conferences

• Reuters·11/13/2025 12:35

  DocGo Inc. Joins BTIG Digital Health Forum Panel on Care Gap Closure and Mobile Health Support

• Dow Jones·11/12/2025 13:15

  DocGo Is Maintained at Hold by Canaccord Genuity

• Dow Jones·11/12/2025 13:15

  DocGo Price Target Cut to $1.50/Share From $1.60 by Canaccord Genuity